Compare CMTL & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMTL | LNSR |
|---|---|---|
| Founded | 1967 | 2004 |
| Country | United States | United States |
| Employees | 1385 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.7M | 146.7M |
| IPO Year | 2024 | 2005 |
| Metric | CMTL | LNSR |
|---|---|---|
| Price | $2.83 | $5.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 594.4K | 37.7K |
| Earning Date | 06-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $499,528,000.00 | $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | $4.56 | $41.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $1.80 | $5.06 |
| 52 Week High | $6.21 | $13.47 |
| Indicator | CMTL | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 32.89 | 50.11 |
| Support Level | $2.73 | $5.34 |
| Resistance Level | $3.49 | $6.20 |
| Average True Range (ATR) | 0.56 | 0.21 |
| MACD | -0.28 | 0.02 |
| Stochastic Oscillator | 6.00 | 58.00 |
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.